J M Wentworth1,2,3,4, J-G Zhang1,2, E Bandala-Sanchez1,2, G Naselli1,2, R Liu1, M Ritchie1,2, G K Smyth1,5, P E O'Brien4, L C Harrison1,2. 1. Department of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. 2. Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia. 3. Department of Medicine, University of Melbourne, Parkville, VIC, Australia. 4. Centre for Obesity Research and Education, Monash University, Melbourne, VIC, Australia. 5. Department of Mathematics and Statistics, University of Melbourne, Parkville, VIC, Australia.
Abstract
BACKGROUND: Inflammatory factors derived from adipose tissue have been implicated in mediating insulin resistance in obesity. We sought to identify these using explanted human adipose tissue exposed to innate and adaptive immune stimuli. METHODS: Subcutaneous and omental adipose tissue from obese, insulin-resistant donors was cultured in the presence of macrophage and T-cell stimuli, and the conditioned medium tested for its ability to inhibit insulin-stimulated glucose uptake into human Simpson-Golabi-Behmel Syndrome (SGBS) adipocytes. The nature of the inhibitory factor in conditioned medium was characterized physicochemically, inferred by gene microarray analysis and confirmed by antibody neutralization. RESULTS: Conditioned medium from omental adipose tissue exposed to a combination of macrophage- and T-cell stimuli inhibited insulin action and adiponectin secretion in SGBS adipocytes. This effect was associated with a pronounced change in adipocyte morphology, characterized by a decreased number of lipid droplets of increased size. The bioactivity of conditioned medium was abolished by trypsin treatment and had a molecular weight of 46 kDa by gel filtration. SGBS adipocytes exposed to a bioactive medium expressed multiple gene transcripts regulated by interferon-gamma (IFN-γ). Recombinant human IFN-γ recapitulated the effects of the bioactive medium and neutralizing antibody against IFN-γ but not other candidate factors abrogated medium bioactivity. CONCLUSIONS: IFN-γ released from inflamed omental adipose tissue may contribute to the metabolic abnormalities seen in human obesity.
BACKGROUND: Inflammatory factors derived from adipose tissue have been implicated in mediating insulin resistance in obesity. We sought to identify these using explanted human adipose tissue exposed to innate and adaptive immune stimuli. METHODS: Subcutaneous and omental adipose tissue from obese, insulin-resistant donors was cultured in the presence of macrophage and T-cell stimuli, and the conditioned medium tested for its ability to inhibit insulin-stimulated glucose uptake into humanSimpson-Golabi-Behmel Syndrome (SGBS) adipocytes. The nature of the inhibitory factor in conditioned medium was characterized physicochemically, inferred by gene microarray analysis and confirmed by antibody neutralization. RESULTS: Conditioned medium from omental adipose tissue exposed to a combination of macrophage- and T-cell stimuli inhibited insulin action and adiponectin secretion in SGBS adipocytes. This effect was associated with a pronounced change in adipocyte morphology, characterized by a decreased number of lipid droplets of increased size. The bioactivity of conditioned medium was abolished by trypsin treatment and had a molecular weight of 46 kDa by gel filtration. SGBS adipocytes exposed to a bioactive medium expressed multiple gene transcripts regulated by interferon-gamma (IFN-γ). Recombinant human IFN-γ recapitulated the effects of the bioactive medium and neutralizing antibody against IFN-γ but not other candidate factors abrogated medium bioactivity. CONCLUSIONS: IFN-γ released from inflamed omental adipose tissue may contribute to the metabolic abnormalities seen in humanobesity.
Authors: G Tiller; H Laumen; P Fischer-Posovszky; A Finck; T Skurk; M Keuper; U Brinkmann; M Wabitsch; D Link; H Hauner Journal: Int J Obes (Lond) Date: 2010-06-15 Impact factor: 5.095
Authors: Sina A Gharib; Amanda L Hurley; Michael J Rosen; James C Spilsbury; Amy E Schell; Reena Mehra; Sanjay R Patel Journal: Sleep Date: 2020-06-15 Impact factor: 5.849
Authors: Aaron R Cox; Natasha Chernis; David A Bader; Pradip K Saha; Peter M Masschelin; Jessica B Felix; Robert Sharp; Zeqin Lian; Vasanta Putluri; Kimal Rajapakshe; Kang Ho Kim; Dennis T Villareal; Reina Armamento-Villareal; Huaizhu Wu; Cristian Coarfa; Nagireddy Putluri; Sean M Hartig Journal: Diabetes Date: 2020-09-29 Impact factor: 9.461
Authors: Emily A Teslow; Cristina Mitrea; Bin Bao; Ramzi M Mohammad; Lisa A Polin; Greg Dyson; Kristen S Purrington; Aliccia Bollig-Fischer Journal: Mol Oncol Date: 2019-03-01 Impact factor: 6.603
Authors: Ada Weinstock; Emily J Brown; Michela L Garabedian; Stephanie Pena; Monika Sharma; Juan Lafaille; Kathryn J Moore; Edward A Fisher Journal: Immunometabolism Date: 2019-07-19
Authors: Eun-Hee Koh; Natasha Chernis; Pradip K Saha; Liuling Xiao; David A Bader; Bokai Zhu; Kimal Rajapakshe; Mark P Hamilton; Xia Liu; Dimuthu Perera; Xi Chen; Brian York; Michael Trauner; Cristian Coarfa; Mandeep Bajaj; David D Moore; Tuo Deng; Sean E McGuire; Sean M Hartig Journal: Diabetes Date: 2018-07-12 Impact factor: 9.461
Authors: Sara Cardellini; Carlo Socci; Massimiliano Bissolati; Fioralba Pindozzi; Anna Giovenzana; Alessandro Saibene; Emanuele Bosi; Manuela Battaglia; Alessandra Petrelli Journal: BMJ Open Diabetes Res Care Date: 2020-04